Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnet Anastomosis System for Type 2 Diabetes
NCT03130244Active, not recruiting
- Sponsor
- GI Windows
- Start
- Sep 2019
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by GI Windows. Primary endpoint: Hemoglobin A1c at 12 months. Started Sep 2019; status: active, not recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT03130244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130244.